or
Bookmark and Share
Multiple drug resistance gene of Aureobasidium pullulans
   
Document Number
US Patent 5516655
Issued Date
May 14, 1996
Link
Inventors
Peery; Robert B. (Indianapolis, IN)
Map
Abstract
The invention provides isolated nucleic acid compounds encoding the multiple drug resistance protein of Aureobasidium pullulans. Vectors and transformed host cells comprising the multiple drug resistance-encoding DNA of Aureobasidium pullulans are also provided. The invention further provides assays which utilize these transformed host cells.
Tags:
Description:
Amusing 0%
Clever 0%
Complex 0%
Efficient 0%
Historic 0%
Important 0%
Innovative 0%
Interesting 0%
Practical 0%
Simple 0%
Number of Claims:
15
Comments:
no comments yet
Owner
Eli Lilly and Company (Indianapolis, IN)
Published
May 14, 1996
Application Number
08/232,537
Filed
April 20, 1994
US Classification
435/69.1   435/252.3 435/254.11 435/320.1 536/23.74
Int'l Classification
C07K   14/37   (20060101)  
Attorney/Law Firm
USPTO Field of Search
435/69.1   435/172.3   435/320.1   435/252.3   435/254.11   435/911   435/240.2   435/240.4   536/23.74   530/823   530/350  
Related Patents
5786463 - Multiple drug resistance gene of Cryptococcus neoformans - Owned by Eli Lilly and Company (Indianapolis, IN)

The invention provides isolated nucleic acid compounds encoding a multiple drug resistance protein of Cryptococcus neoformans. Vectors and transformed host cells comprising the multiple drug resistance-encoding DNA of Cryptococcus neoformans CneMDR1 are also provided. The invention further provides assays which utilize these transformed host cells.

5914246 - Multiple drug resistance gene of Aspergillus fumigatus - Owned by Eli Lilly and Company (Indianapolis, IN)

The invention provides isolated nucleic acid compounds encoding a multiple drug resistance protein of Aspergillus fumigatus. Vectors and transformed host cells comprising the multiple drug resistance-encoding DNA of Aspergillus fumigatus AfuMDR1 are also provided. The invention further provides assays which utilize these transformed host cells.

5945324 - Multiple drug resistance gene ATRC of aspergillus nidulans - Owned by Eli Lilly and Company (Indianapolis, IN)

The invention provides isolated nucleic acid compounds encoding a multiple drug resistance protein of Aspergillus nidulans. Vectors and transformed host cells comprising the multiple drug resistance-encoding DNA of Aspergillus nidulans atrC are also provided. The invention further provides assays which utilize these transformed host cells.

5773214 - Multiple drug resistance gene of aspergillus flavus - Owned by Eli Lilly and Company (Indianapolis, IN)

The invention provides isolated nucleic acid compounds encoding a multiple drug resistance protein of Aspergillus flavus. Vectors and transformed host cells comprising the multiple drug resistance-encoding DNA of Aspergillus flavus MDR-1 are also provided. The invention further provides assays which utilize these transformed host cells.

Claims
Description
About| FAQs| Terms & Disclaimer| Link to Us| Contact Us